Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, signaling a new version in the revision history rather than a modification to the study content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows recruitment as no longer looking for participants, and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. A formatting change updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag to v3.6.0.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.0%

- Check34 days agoChange DetectedNew May 2026 update dates were added to the Study Record Dates (2026-05-22, 2026-05-27, and 2026-05), while older March 2026 dates (2026-03-10, 2026-03-27, and 2026-03) were removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.0%

- Check62 days agoChange DetectedA new page revision tag v3.5.3 was added, replacing the previous v3.5.2. This is a metadata-level change that does not alter visible content or user interactions.SummaryDifference0.0%

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.